Unknown

Dataset Information

0

Inferring clonal heterogeneity in cancer using SNP arrays and whole genome sequencing.


ABSTRACT: MOTIVATION:Clonal heterogeneity is common in many types of cancer, including chronic lymphocytic leukemia (CLL). Previous research suggests that the presence of multiple distinct cancer clones is associated with clinical outcome. Detection of clonal heterogeneity from high throughput data, such as sequencing or single nucleotide polymorphism (SNP) array data, is important for gaining a better understanding of cancer and may improve prediction of clinical outcome or response to treatment. Here, we present a new method, CloneSeeker, for inferring clinical heterogeneity from sequencing data, SNP array data, or both. RESULTS:We generated simulated SNP array and sequencing data and applied CloneSeeker along with two other methods. We demonstrate that CloneSeeker is more accurate than existing algorithms at determining the number of clones, distribution of cancer cells among clones, and mutation and/or copy numbers belonging to each clone. Next, we applied CloneSeeker to SNP array data from samples of 258 previously untreated CLL patients to gain a better understanding of the characteristics of CLL tumors and to elucidate the relationship between clonal heterogeneity and clinical outcome. We found that a significant majority of CLL patients appear to have multiple clones distinguished by copy number alterations alone. We also found that the presence of multiple clones corresponded with significantly worse survival among CLL patients. These findings may prove useful for improving the accuracy of prognosis and design of treatment strategies. AVAILABILITY AND IMPLEMENTATION:Code available on R-Forge: https://r-forge.r-project.org/projects/CloneSeeker/. SUPPLEMENTARY INFORMATION:Supplementary data are available at Bioinformatics online.

SUBMITTER: Zucker MR 

PROVIDER: S-EPMC6736450 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inferring clonal heterogeneity in cancer using SNP arrays and whole genome sequencing.

Zucker Mark R MR   Abruzzo Lynne V LV   Herling Carmen D CD   Barron Lynn L LL   Keating Michael J MJ   Abrams Zachary B ZB   Heerema Nyla N   Coombes Kevin R KR  

Bioinformatics (Oxford, England) 20190901 17


<h4>Motivation</h4>Clonal heterogeneity is common in many types of cancer, including chronic lymphocytic leukemia (CLL). Previous research suggests that the presence of multiple distinct cancer clones is associated with clinical outcome. Detection of clonal heterogeneity from high throughput data, such as sequencing or single nucleotide polymorphism (SNP) array data, is important for gaining a better understanding of cancer and may improve prediction of clinical outcome or response to treatment.  ...[more]

Similar Datasets

| S-EPMC2592714 | biostudies-literature
| S-EPMC4253833 | biostudies-other
| S-EPMC1458964 | biostudies-literature
| S-EPMC2739861 | biostudies-other
| S-EPMC2432039 | biostudies-literature
| S-EPMC4744563 | biostudies-literature
2008-09-18 | GSE11976 | GEO
| S-EPMC2587696 | biostudies-literature
| S-EPMC2879364 | biostudies-literature
| S-EPMC4023602 | biostudies-literature